Search Results - "Bugano, Diogo G"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs by Bugano, Diogo D G, Hess, Kenneth, Jardim, Denis L F, Zer, Alona, Meric-Bernstam, Funda, Siu, Lillian L, Razak, Albiruni R A, Hong, David S

    Published in Clinical cancer research (01-08-2017)
    “…Evaluate the association between the use of phase I expansion cohorts (ECs) and drug performance in phase II as well as time to approval by the FDA. We…”
    Get full text
    Journal Article
  2. 2

    Teicoplanin versus vancomycin for proven or suspected infection by Cavalcanti, Alexandre B, Goncalves, Anderson R, Almeida, Claudia S, Bugano, Diogo Dg, Silva, Eliezer

    Published in Cochrane database of systematic reviews (16-06-2010)
    “…Vancomycin and teicoplanin are commonly used to treat gram-positive infections, particularly those caused by methicillin-resistant Staphylococcus aureus…”
    Get more information
    Journal Article
  3. 3

    Oncologic aspects of the decision-making process for surgical approach for colorectal liver metastases progressing during chemotherapy by Araujo, Raphael L C, Carvalho, Camila G C Y, Maeda, Carlos T, Milani, Jean Michel, Bugano, Diogo G, de Moraes, Pedro Henrique Z, Linhares, Marcelo M

    Published in World journal of gastrointestinal surgery (27-09-2022)
    “…Colorectal cancer represents the third most diagnosed malignancy in the world. The liver is the main site of metastatic disease, affected in 30% of patients…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic Cancer by Usón Junior, Pedro L. S., Callegaro-Filho, Donato, Bugano, Diogo D. G., Moura, Fernando, Maluf, Fernando C.

    Published in Journal of gastrointestinal cancer (01-12-2018)
    “…Introduction Levels of carbohydrate antigen 19-9 (CA19-9) in metastatic pancreatic cancer are used in daily practice as a marker of response to chemotherapy…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8